ARCHIVES

ODAC Advice Poses Challenge to FDA: Would Iressa Approval Erode Standards?

This article is from The Cancer Letter archive.

Vol. 28 No. 41 | November 8, 2002

Download PDF Visit The Full Archive

Related Articles

Daniel Hayes Elected President of ASCO

December 12, 2014

Bill Would Harm Pancreatic Cancer Research – Scientists Warn Of Unintended Consequences

August 10, 2012

No Interest Seen Yet In Specialized Centers For Environmental Carcinogenesis

September 26, 1975

Black Women More Likely To Have Aggressive, Less Treatable Breast Cancer

September 28, 2007

DCT Board Insists On Being Heard In Development Of CCOP Guidelines

February 19, 1982

Includes May issue of Business & Regulatory Report.

May 31, 2002